Compare · Ave, AS Company
Share prices with dividends, events and key figures
AVEAveFocusASCOAS Company
Trend · vs peers
Ave: -10.4% against a peer median of +24.1%, 34.5 points apart
% since 27/10/2025, dividends included
Show
Coming up
| Return · 1Y | |
|---|---|
| AS Company · ASCO | +24.1% |
| Ave · AVE | −10.4% |
Athens Stock Exchange closes, adjusted for dividends · xrimatistirio
Ask MENTOR about this comparison
Key figures
| AVE | ASCOlike-for-like | Peer median1 counted | ||
|---|---|---|---|---|
| Price | ||||
| Price | €0.455 | €4.57 | ||
| Return, 1Y | −10.4% | +24.1% | +24.1% | |
| From its 52-week high | −14.8% | −7.5% | ||
| Size and growth | ||||
| Market value | €81.1m | €59.4m | ||
| Revenue, last 12 months | €31.1m | €36.7m | ||
| Revenue growth, latest year | +8.2% | +16.4% | ||
| Latest results: revenue | — | +4.2%H1 2026 | ||
| Profitability | ||||
| EBITDA margin | −8.4% | 23.9% | ||
| Net margin | −7.4% | 18.2% | ||
| Return on equity | −25.2% | 15.9% | ||
| Balance sheet | ||||
| Net debt | €11.0m | −€25.8m | ||
| Net debt / EBITDA | — | -2.9× | ||
| Valuation | ||||
| EV/EBITDAthe measure for this business | — | 3.8× | ||
| P/E | — | 10× | ||
| P/B | 9.6× | 1.4× | ||
| Shareholder returns | ||||
| Dividend yield | 0.0% | 5.5% | ||
Price
AVE€0.455
ASCO€4.57
Return, 1YPeer median +24.1%
AVE−10.4%
ASCO+24.1%
From its 52-week high
AVE−14.8%
ASCO−7.5%
Peer median: the companies ticked (like-for-like ones to start with). A flagged figure is left out and shown faint; hover for the reason. It needs two figures, one for a return.
Valuation, margins and debt: latest reported twelve months · growth: company reports, from the reviewed dossiers · latest results: exchange announcements
Five years
- Ave
- AS Company
Revenue
2021 = 100
EBITDA margin
%
Net margin
%
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue · AVE | €142.9m | €16.4m | €19.4m | €28.8m | €31.1m |
| Revenue · ASCO | €22.7m | €28.7m | €28.7m | €31.0m | €36.1m |
| EBITDA · AVE | €2.5m | €-3.8m | €-3.2m | €-4.6m | €-2.6m |
| EBITDA · ASCO | €3.9m | €4.7m | €5.5m | €5.2m | €8.1m |
| Net income · AVE | €-7.0m | €-5.6m | €-9.8m | €2.3m | €-2.3m |
| Net income · ASCO | €3.2m | €2.6m | €4.5m | €4.2m | €5.8m |
Company annual reports, from the reviewed dossiers · to 23/10/2026